{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for tyrosine in Related Substance Name (approximate match)
Status:
Investigational
Source:
NCT04692831: Phase 1 Interventional Active, not recruiting HER-2 Positive Malignant Carcinoma of Breast
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03795142: Early Phase 1 Interventional Completed Healthy Volunteers
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01832051: Phase 2 Interventional Completed Metastatic Breast Cancer
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mecbotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:anzurstobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03500380: Phase 2/Phase 3 Interventional Active, not recruiting Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04165993: Phase 2 Interventional Active, not recruiting Metastatic Breast Cancer
(2019)
Source URL:
Class:
PROTEIN